Elli Peselev

Array ( [id] => 5265821 [patent_doc_number] => 20090118506 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-05-07 [patent_title] => '6,11-BRIDGED BIARYL MACROLIDES' [patent_app_type] => utility [patent_app_number] => 12/212596 [patent_app_country] => US [patent_app_date] => 2008-09-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 30289 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0118/20090118506.pdf [firstpage_image] =>[orig_patent_app_number] => 12212596 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5272139 [patent_doc_number] => 20090075915 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-03-19 [patent_title] => '6,11-BICYCLOLIDES: BRIDGED BIARYL MACROLIDE DERIVATIVES' [patent_app_type] => utility [patent_app_number] => 12/212447 [patent_app_country] => US [patent_app_date] => 2008-09-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17919 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0075/20090075915.pdf [firstpage_image] =>[orig_patent_app_number] => 12212447 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5585961 [patent_doc_number] => 20090105163 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-04-23 [patent_title] => 'Conjugates of Immune Cell Specific Macrolide Compounds with Anti-Inflammatory Compounds for Improved Cellular Targeting of Anti-Inflammatory Therapy' [patent_app_type] => utility [patent_app_number] => 12/211213 [patent_app_country] => US [patent_app_date] => 2008-09-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7828 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0105/20090105163.pdf [firstpage_image] =>[orig_patent_app_number] => 12211213 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5272141 [patent_doc_number] => 20090075917 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-03-19 [patent_title] => 'DEUTERIUM-ENRICHED TELITHROMYCIN' [patent_app_type] => utility [patent_app_number] => 12/210405 [patent_app_country] => US [patent_app_date] => 2008-09-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3112 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0075/20090075917.pdf [firstpage_image] =>[orig_patent_app_number] => 12210405 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8995014 [patent_doc_number] => 08518898 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-08-27 [patent_title] => 'Cytoprotective composition comprising hesperidin or pharmaceutically acceptable salt thereof as an active ingredient' [patent_app_type] => utility [patent_app_number] => 12/208643 [patent_app_country] => US [patent_app_date] => 2008-09-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 8444 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 60 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12208643 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5539713 [patent_doc_number] => 20090221518 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-09-03 [patent_title] => 'Compositions and Methods for Treatment of Exudative Serous Effusion' [patent_app_type] => utility [patent_app_number] => 12/205183 [patent_app_country] => US [patent_app_date] => 2008-09-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4769 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0221/20090221518.pdf [firstpage_image] =>[orig_patent_app_number] => 12205183 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5324231 [patent_doc_number] => 20090062221 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-03-05 [patent_title] => 'Azithromycin for treatment of skin disorders' [patent_app_type] => utility [patent_app_number] => 12/231586 [patent_app_country] => US [patent_app_date] => 2008-09-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 12934 [patent_no_of_claims] => 50 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0062/20090062221.pdf [firstpage_image] =>[orig_patent_app_number] => 12231586 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6637416 [patent_doc_number] => 20100173862 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-07-08 [patent_title] => 'INJECTABLE, INJECTION SOLUTION, AND INJECTION KIT PREPARATION' [patent_app_type] => utility [patent_app_number] => 12/676291 [patent_app_country] => US [patent_app_date] => 2008-09-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4321 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0173/20100173862.pdf [firstpage_image] =>[orig_patent_app_number] => 12676291 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5453218 [patent_doc_number] => 20090069255 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-03-12 [patent_title] => 'DEUTERIUM-ENRICHED CLARITHROMYCIN' [patent_app_type] => utility [patent_app_number] => 12/202278 [patent_app_country] => US [patent_app_date] => 2008-08-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3385 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0069/20090069255.pdf [firstpage_image] =>[orig_patent_app_number] => 12202278 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9440918 [patent_doc_number] => 08710028 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-04-29 [patent_title] => 'Pharmaceutical powder compositions' [patent_app_type] => utility [patent_app_number] => 12/675306 [patent_app_country] => US [patent_app_date] => 2008-08-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 4928 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 151 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12675306 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5324230 [patent_doc_number] => 20090062220 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-03-05 [patent_title] => 'DEUTERIUM-ENRICHED AZITHROMYCIN' [patent_app_type] => utility [patent_app_number] => 12/195540 [patent_app_country] => US [patent_app_date] => 2008-08-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3104 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0062/20090062220.pdf [firstpage_image] =>[orig_patent_app_number] => 12195540 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5446979 [patent_doc_number] => 20090048205 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-02-19 [patent_title] => 'COMBINATION THERAPY WITH SYNTHETIC TRITERPENOIDS AND GEMCITABINE' [patent_app_type] => utility [patent_app_number] => 12/192710 [patent_app_country] => US [patent_app_date] => 2008-08-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 14792 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0048/20090048205.pdf [firstpage_image] =>[orig_patent_app_number] => 12192710 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7703070 [patent_doc_number] => 08088824 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-01-03 [patent_title] => 'Forms of CDDO methyl ester' [patent_app_type] => utility [patent_app_number] => 12/191176 [patent_app_country] => US [patent_app_date] => 2008-08-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 30 [patent_figures_cnt] => 30 [patent_no_of_words] => 16403 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/088/08088824.pdf [firstpage_image] =>[orig_patent_app_number] => 12191176 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8458049 [patent_doc_number] => 08293715 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-10-23 [patent_title] => '10a-Azalide compound crosslinked at 10a- and 12-positions' [patent_app_type] => utility [patent_app_number] => 12/671813 [patent_app_country] => US [patent_app_date] => 2008-08-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 145569 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12671813 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5310809 [patent_doc_number] => 20090018090 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-01-15 [patent_title] => 'PROCESS FOR PREPARATION OF ANHYDROUS AZITHROMYCIN' [patent_app_type] => utility [patent_app_number] => 12/184051 [patent_app_country] => US [patent_app_date] => 2008-07-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 3533 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0018/20090018090.pdf [firstpage_image] =>[orig_patent_app_number] => 12184051 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6535778 [patent_doc_number] => 20100204163 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-08-12 [patent_title] => 'METABOLITES AND DERIVATIVES OF AMBRISENTAN' [patent_app_type] => utility [patent_app_number] => 12/671439 [patent_app_country] => US [patent_app_date] => 2008-07-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 8173 [patent_no_of_claims] => 47 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0204/20100204163.pdf [firstpage_image] =>[orig_patent_app_number] => 12671439 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5416935 [patent_doc_number] => 20090042822 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-02-12 [patent_title] => 'METHOD TO ENHANCE DELIVERY OF GLUTATHIONE AND ATP LEVELS IN CELLS' [patent_app_type] => utility [patent_app_number] => 12/182354 [patent_app_country] => US [patent_app_date] => 2008-07-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 3777 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0042/20090042822.pdf [firstpage_image] =>[orig_patent_app_number] => 12182354 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5361594 [patent_doc_number] => 20090036388 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-02-05 [patent_title] => 'Compounds' [patent_app_type] => utility [patent_app_number] => 12/180675 [patent_app_country] => US [patent_app_date] => 2008-07-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19226 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0036/20090036388.pdf [firstpage_image] =>[orig_patent_app_number] => 12180675 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9440909 [patent_doc_number] => 08710019 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-04-29 [patent_title] => 'Topical antibiotic composition for the prevention of Lyme disease' [patent_app_type] => utility [patent_app_number] => 12/452805 [patent_app_country] => US [patent_app_date] => 2008-07-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5712 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 66 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12452805 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6465539 [patent_doc_number] => 20100190736 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-07-29 [patent_title] => 'MORPHOLINYL ANTHRACYCLINE DERIVATIVE COMBINED WITH PROTEIN KINASE INHIBITORS' [patent_app_type] => utility [patent_app_number] => 12/671246 [patent_app_country] => US [patent_app_date] => 2008-07-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3324 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0190/20100190736.pdf [firstpage_image] =>[orig_patent_app_number] => 12671246 [rel_patent_id] =>[rel_patent_doc_number] =>)